Clinical Trial Update: A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris [Phase 1]

View source ↗

Summary

Phase 1 study comparing tazarotene 0.1% cream and Tazorac to placebo for acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• TAZORAC (Tazarotene)
• Tazarotene cream 0.1% (Tazarotene)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED